Evidence map›Paper›PMID 36131127›Full record

ArticleClinical hematology international2022

Organizational Challenges in the Pediatric Onco-hematology Units During the First and Second Wave of the COVID-19 Pandemic: A National Survey in Italy.

Matteo Amicucci, Valentina Biagioli, Elena Rostagno, Marta Canesi, Anna Bergadano, Debora Botta, Moreno Crotti Partel

Open access · diamondAbstract read
In one paragraph

Article in Clinical hematology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Frequency and patterns of CMF emergency cases during and after COVID-19.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 1 country.

Matteo AmicucciDepartment of Onco Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant'Onofrio Square, 4, 00165, Rome, Italy. matteo.amicucci@opbg.net.
Valentina BiagioliProfessional Development, Continuing Education and Research Service, Bambino Gesù Children's Hospital, IRCCS, Piazza S. Onofrio, 4, 00165, Rome, Italy.
Elena RostagnoPediatric Oncology and Hematology Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna, Via Massarenti, 11, 40138, Bologna, Italy.
Marta CanesiPediatric Hematology and BMT Unit, Fondazione MBBM Onlus - Clinica Pediatrica Università degli Studi Milano Bicocca, Via Pergolesi, 33, 20900, Monza, Italy.
Anna BergadanoPediatric Hematology and Oncology Stem Cell Transplantation and Cellular Therapy Division, Presidio Infantile Regina Margherita, Piazza Polonia, 94, 10126, Turin, Italy.
Debora BottaPediatric Unit, Ospedale Santissima Annunziata-Asl Cn1, Via degli Ospedali 14, 12038, Savigliano, Italy.
Moreno Crotti PartelBachelor of Science in Nursing, ASST Spedali Civili - University of Brescia, Viale Europa, 15, 25123, Brescia, Italy.
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITAzienda USL di Bologna · ITBambino Gesù Children's Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale Regina Margherita · ITOspedale SS. Annunziata · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to describe and compare, at a national level, the measures implemented in the pediatric onco-hematology units and the number of infections among patients and healthcare staff during the first and second wave of the COVID-19 pandemic in Italy. A multicenter, descriptive, online survey was conducted between15th March and 15th April 2020 (T1) and between 1 and 31st January 2021 (T2). All the Italian Pediatric Oncology and Hematology Association (AIEOP) centers were invited to participate in the study. Data of the pre-pandemic, first, and second phase were compared. Thirty-six of the 48 AIEOP centers completed the survey (75%). Several organizational, screening, and swab measures were implemented by AIEOP centers to prevent the SARS-CoV-2 infection among patients and visitors. During the pandemic, there was a significant reduction in the number of onco-hematology inpatient beds (p < 0.001), including inpatient beds dedicated to hematopoietic stem cell transplantation (HSCT), and consultations in the outpatient clinics (p < 0.001). During the first wave, 37 pediatric patients with cancer tested positive for SARS-CoV-2 versus 174 patients during the second wave. The reduction in routine services was also greater in the second than in the first wave. All the AIEOP centers showed the capacity to adapt and promptly respond to both waves of the pandemic.

Indexed as

CancerCOVID-19HematologyOncologyPediatrics

Identifiers

PMID36131127
PMCPMC9223269
OpenAlexW4283331133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.